Minnesota Statutes
Chapter 62J — Health Care Cost Containment
Section 62J.80 — Retaliation.

A health plan company or health care provider shall not retaliate or take adverse action against an enrollee or patient who, in good faith, makes a complaint against a health plan company or health care provider. If retaliation is suspected, the executive director may report it to the appropriate regulatory authority.
1998 c 407 art 2 s 18

Structure Minnesota Statutes

Minnesota Statutes

Chapters 59A - 79A — Insurance

Chapter 62J — Health Care Cost Containment

Section 62J.01 — Findings.

Section 62J.015 — Purpose.

Section 62J.016 — Goals Of Restructuring.

Section 62J.017 — Implementation Timetable.

Section 62J.03 — Definitions.

Section 62J.04 — Monitoring The Rate Of Growth Of Health Care Spending.

Section 62J.041 — Interim Health Plan Company Cost Containment Goals.

Section 62J.052 — Provider Cost Disclosure.

Section 62J.06 — Immunity From Liability.

Section 62J.156 — Closed Committee Hearings.

Section 62J.17 — Expenditure Reporting.

Section 62J.212 — Public Health Goals.

Section 62J.22 — Participation Of Federal Programs.

Section 62J.23 — Provider Conflicts Of Interest.

Section 62J.25 — Mandatory Medicare Assignment.

Section 62J.26 — Evaluation Of Proposed Health Coverage Mandates.

Section 62J.2930 — Information Clearinghouse.

Section 62J.301 — Research And Data Initiatives.

Section 62J.311 — Analysis And Use Of Data.

Section 62J.321 — Data Collection And Processing Procedures.

Section 62J.38 — Cost Containment Data From Group Purchasers.

Section 62J.40 — Cost Containment Data From State Agencies And Other Governmental Units.

Section 62J.42 — Quality, Utilization, And Outcome Data.

Section 62J.431 — Evidence-based Health Care Guidelines.

Section 62J.46 — Monitoring And Reports.

Section 62J.48 — Criteria For Ambulance Services Reimbursement.

Section 62J.49 — Ambulance Services Financial Data.

Section 62J.495 — Electronic Health Record Technology.

Section 62J.496 — Electronic Health Record System Revolving Account And Loan Program.

Section 62J.497 — Electronic Prescription Drug Program.

Section 62J.498 — Health Information Exchange.

Section 62J.4981 — Certificate Of Authority To Provide Health Information Exchange Services.

Section 62J.4982 — Enforcement Authority; Compliance.

Section 62J.50 — Citation And Purpose.

Section 62J.51 — Definitions.

Section 62J.52 — Establishment Of Uniform Billing Forms.

Section 62J.53 — Acceptance Of Uniform Billing Forms By Group Purchasers.

Section 62J.535 — Uniform Billing Requirements For Claim Transactions.

Section 62J.536 — Uniform Electronic Transactions And Implementation Guide Standards.

Section 62J.54 — Identification And Implementation Of Unique Identifiers.

Section 62J.55 — Privacy Of Unique Identifiers.

Section 62J.56 — Implementation Of Electronic Data Interchange Standards.

Section 62J.57 — Minnesota Center For Health Care Electronic Data Interchange.

Section 62J.581 — Standards For Minnesota Uniform Health Care Reimbursement Documents.

Section 62J.60 — Minnesota Uniform Health Care Identification Card.

Section 62J.61 — Rulemaking; Implementation.

Section 62J.62 — Electronic Billing Assistance.

Section 62J.63 — Center For Health Care Purchasing Improvement.

Section 62J.691 — Purpose.

Section 62J.692 — Medical Education.

Section 62J.695 — Citation.

Section 62J.70 — Definitions.

Section 62J.701 — Governmental Programs.

Section 62J.71 — Prohibited Provider Contracts.

Section 62J.72 — Disclosure Of Health Care Provider Information.

Section 62J.73 — Prohibition On Exclusive Arrangements.

Section 62J.74 — Enforcement.

Section 62J.76 — Nonpreemption.

Section 62J.80 — Retaliation.

Section 62J.81 — Disclosure Of Payments For Health Care Services.

Section 62J.812 — Primary Care Price Transparency.

Section 62J.82 — Hospital Information Reporting Disclosure.

Section 62J.823 — Hospital Pricing Transparency.

Section 62J.824 — Facility Fee Disclosure.

Section 62J.83 — Reduced Payment Amounts Permitted.

Section 62J.84 — Prescription Drug Price Transparency.